Viral Vector Manufacturing Market Research by Segmentation and Diagnosis Analysis Report
Viral Vector Manufacturing Market Highlights: It is projected that the global viral vector manufacturing market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period from 2018 to 2023. Gene therapy is one of the preferred treatment options for most chronic diseases, involving insertion of a functional copy of a gene into a defective cell.
Viral vector methods are used in effective transfer of therapeutic gene into the target cells.
Several factors such as growing necessity for an effective mode of disease treatment, rise in the number of clinical trials and increase in the number of gene therapy candidates are likely to drive the growth of the market. On the other hand, high cost of gene therapies and possible mutagenesis may hinder the growth of the market during the forecast period.
Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/6890
Key Players:
Some of the key players in the global viral vector manufacturing market are FinVector Vision Therapies, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., and Kaneka Eurogentec S.A.
Segmentation:
The global viral vector manufacturing market has been segmented into type, disease, application, and end-user.
The market, on the basis of type, has been segmented retroviral vectors, adenoviral vectors, adeno-associated viral vectors, and other viral vectors.
The market, by retroviral vectors, has been further segmented into lentiviral vectors and gamma-retroviral vectors.
The market, by disease, has been segmented into cancer, genetic disorders, infectious diseases, and others.
The market, by application, has been segmented into gene therapy and vaccinology.
The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, research institutes, and others. The market, by pharmaceutical and biotechnology companies, is expected to hold the largest share in the market owing to the increasing demand for therapies, whereas the research institutes segment is projected to be the fastest growing segment due to growing awareness and specificity of viral vectors in treating the diseases.
Browse Complete Report Details at https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312